Seeking Alpha

MeiraGTx Announces Two Posters at the European Society of Gene and Cell Therapy (ESGCT ...

LONDON and NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the Company will exhibit two ...
Business Wire

Kamau Therapeutics Emerges from Stealth With Clinical-Stage Novel Gene Correction ...

SAN FRANCISCO--(BUSINESS WIRE)--Kamau Therapeutics ("Kamau" or "the Company"), a clinical-stage gene correction company, announced today its emergence from stealth, following a strategic transaction ...
Seeking Alpha

MeiraGTx Announces Poster Presentation on a Potential Treatment for MC4R Genetic Deficiency ...

LONDON and NEW YORK, Oct. 09, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings (MGTX) plc , a vertically integrated, clinical stage genetic medicine company, today announced a poster presentation at the ...
Wane

MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and ...

MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting Multiple Poster Presentations Highlight the Depth and Novelty of ...